Although Unproven, Some Advocates Believe the Technology Can Save Both Time and Money The current approach to drug development has not served the industry well. Fewer drugs are being approved, even as ...
In silico modeling is becoming a valuable and accurate prediction tool, despite its early, spotty reputation. The increase in information from metabolomics, proteomics, and genomics projects, plus ...
The "In Silico Clinical Trials Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market is undergoing rapid transformation, ...
This webinar examines the benefits of combining Liver-on-a-chip with in silico modeling to explore clinical PK predictions of specific reference drugs, including investigations into the intrinsic ...
AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was USD 3.76 billion in 2023, increased to USD 3.95 billion in 2024, ...
Multi-omics analysis uncovers prognostic biomarkers and tumor ecosystem dynamics during sequential neoadjuvant treatment of dose-limiting chemotherapy combined with sintilimab for non-small cell lung ...
Chemical and biochemical processes can be modeled in silico based on knowledge of the molecular structure of the species involved and understanding basic chemical interactions, allowing such processes ...
Upstream Bio, Inc. presented data at the European Academy of Allergy & Clinical Immunology Congress highlighting the advantages of verekitug, a treatment targeting the TSLP receptor, over tezepelumab, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback